Future of the Biotech Ingredient Market: Strategic Analysis and Forecast to 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Biotech Ingredient Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of biotech ingredients has seen a robust growth in the past few years. The market, which was valued at $59.9 billion in 2024, is expected to increase to $63.25 billion in 2025, marking a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this growth during the historic period include breakthroughs in the food and beverage sector, a growing uptake of biofuel, rising consumer preference for functional foods, and advancements in genetic engineering.

Biotech Ingredient Market Size Forecast: What's the Projected Valuation by 2029?
The biotech ingredient industry is anticipated to witness robust expansion in the forthcoming years, with its market size projected to reach $81.66 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. The predicted upswing during the forecast period is driven by factors such as the attention to personalized nutrition, rise in cell-based meat production, advancement in therapeutic biotech ingredients, the use of bio ingredients for waste reduction, and the transition to bioplastics. The primary trends in the forecast span will be those of biotech-enhanced functional food products, biotech strategies for circular economy measures, therapeutic biotech ingredients, biotech ingredients for sustainable energy production, and a global focus on biodiversity conservation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

What Are the Drivers Transforming the Biotech Ingredient Market?
The surge in the need for generic drugs is anticipated to stimulate the expansion of the biotech ingredient industry. Generic drugs are designed to mirror the properties of previously authorised drugs. Biotech components serve a crucial role in general medicine, acting as an affordable and effective source for creating various active ingredients that are virtually identical to the original product. They usually operated under a comprehensive regulatory framework. For instance, as indicated by the Personalized Medicine Coalition, a US professional membership body, in 2022, 12 new personalized drugs accounted for approximately 34% of all freshly sanctioned therapies. This represents a substantial increment from previous years. Consequently, escalated demands for generic drugs act as a driving factor for the growth of the biotech ingredient market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Trends Will Shape the Biotech Ingredient Market Through 2029 and Beyond?
The growing popularity of technology development is becoming a major trend in the biotech ingredient sector. To solidify their standings in the market, leading corporations are implementing fresh technologies to create inventive products. For example, in March 2023, International Flavors & Fragrances Inc., a U.S. firm specializing in fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, launched a new biopolymer for hair care named Aurist AGC. This showcases the potential of the new DEB platform by leveraging IFF's extensive biotech capabilities to guarantee long-lasting and exceptional glamour solutions that can genuinely bring change to the cosmeceutical sector. The ingredient employs IFF's proprietary Designed Enzymatic Biopolymers (DEB) technology, a high-tech biotechnology system capable of generating unique biobased polysaccharides with distinct structures and product characteristics.

Which Segments in the Biotech Ingredient Market Offer the Most Profit Potential?
The biotech ingredient market covered in this report is segmented -

1) By Type: Active Pharmaceutical Ingredients, Biosimilars
2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems
3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:
1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs
2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

Which Firms Dominate the Biotech Ingredient Market by Market Share and Revenue in 2025?
Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Which Regions Offer the Highest Growth Potential in the Biotech Ingredient Market?
Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9817

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.